Cargando…

Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study

OBJECTIVES: Metastatic renal cell carcinoma can occur synchronously or metachronously. We characterized the time from diagnosis to systematic therapy as a categorical variable to analyze its effect on the overall survival and first‐line treatment efficacy of metastatic renal cell carcinoma patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Chuanzhen, Shou, Jianzhong, Shi, Hongzhe, Jiang, Weixing, Kang, Xiangpeng, Xie, Ruiyang, Shang, Bingqing, Bi, Xingang, Zhang, Jin, Zheng, Shan, Zhou, Aiping, Li, Changling, Ma, Jianhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles: Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299735/ https://www.ncbi.nlm.nih.gov/pubmed/34847622 http://dx.doi.org/10.1111/iju.14751

Ejemplares similares

Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety
por: Xie, Ruiyang, et al.
Publicado: (2022)

A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy
por: Shang, Bingqing, et al.
Publicado: (2022)

Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus
por: Shang, Bingqing, et al.
Publicado: (2021)

Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis
por: Xie, Ruiyang, et al.
Publicado: (2021)

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma
por: Xie, Ruiyang, et al.
Publicado: (2022)

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma
por: Kang, Xiangpeng, et al.
Publicado: (2020)

Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target
por: Shang, Bingqing, et al.
Publicado: (2023)

Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma
por: Shi, Hongzhe, et al.
Publicado: (2022)

Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database
por: Jiang, Weixing, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy–Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
por: Shi, Hongzhe, et al.
Publicado: (2021)

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus
por: Cao, Chuanzhen, et al.
Publicado: (2019)

Cut off values for abdominal obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz population (Central Asian region)
por: Mirrakhimov, Aibek E, et al.
Publicado: (2012)

Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma
por: Guo, Liping, et al.
Publicado: (2020)

Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis
por: Bai, Hongsong, et al.
Publicado: (2022)

Proposal for Cut-off Scores for Sensitive Skin on Sensitive Scale-10 in a Group of Adult Women
por: LEGEAS, Cécile, et al.
Publicado: (2021)

A Muscle-Invasive Bladder Cancer Patient With High Tumor Mutational Burden and RB1 Mutation Achieved Bladder Preservation Following Chemotherapy Combined With Immunotherapy: A Case Report
por: Cao, Chuanzhen, et al.
Publicado: (2021)

Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma
por: Sebastian, Nikhil T., et al.
Publicado: (2019)

Comparison of VerifyNow-P2Y(12 )test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
por: Godino, Cosmo, et al.
Publicado: (2009)

Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study
por: Guan, Youyan, et al.
Publicado: (2022)

Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
por: Oshima, Sonoko, et al.
Publicado: (2023)

Dynamic monitoring of menopause hormone therapy and defining the cut-off value of endometrial thickness during uterine bleeding
por: Sheng, Qiu, et al.
Publicado: (2016)

Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia
por: Azevedo, M.C., et al.
Publicado: (2014)

When to set anticoagulant therapy in asymptomatic AF? looking for a cut-off duration
por: Rossini, Roberta, et al.
Publicado: (2022)

Comparison of image quality and radiation dose between prospectively ECG-triggered and retrospectively ECG-gated CT angiography: Establishing heart rate cut-off values in first-generation dual-source CT
por: Ünal, Emre, et al.
Publicado: (2015)

Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs
por: Altman, Raul, et al.
Publicado: (2015)

Cut-off models of the proton
por: Hofstadter, Robert
Publicado: (1959)

On Cutting off the Tails of Leeches
Publicado: (1816)

Reunion of Cut-off Tongue
Publicado: (1891)

Reunion of Cut off Tongue
Publicado: (1890)

Reunion of Cut-off Fingers
Publicado: (1892)

Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

The Cut-off Values for the Diagnosis of Hamstring Shortness and Related Factors
por: Yıldırım, Muhammed Şeref, et al.
Publicado: (2018)

Cut-Off Value of Medial Meniscal Extrusion for Knee Pain
por: Kijima, Hiroaki, et al.
Publicado: (2017)

Cut-Off Values of Foveal Vascular Indices in Exfoliation Glaucoma
por: Kocatürk, Tolga, et al.
Publicado: (2021)

Cut-Off Values in the Prediction of Success in Olympic Distance Triathlon
por: Gadelha, André Bonadias, et al.
Publicado: (2020)

Molecular Cut-off Values for Aliarcobacter butzleri Susceptibility Testing
por: Jehanne, Quentin, et al.
Publicado: (2022)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study
por: Berlanga, Pablo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4trlfevmnndv9hh81de3v6imva